Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in NAFLD
NCT00736385Phase 4Terminated
- Sponsor
- Duke University
- Start
- Apr 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in non-alcoholic fatty liver disease (NAFLD), sponsored by Duke University. Started Apr 2009; status: terminated.
02
Drugs
metformin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT00736385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736385.